E29.1 ICD-10-CM Code: Testicular hypofunction
E29.1 is the billable ICD-10-CM code for “Testicular hypofunction” in the FY 2027 U.S. code set, effective Oct 1, 2026.
Official description
E29.1Testicular hypofunction
ICD-10-CM diagnosis code · United States clinical modification
Where E29.1 sits
- 1
Chapter 4
Endocrine, nutritional and metabolic diseases (E00-E89)
- 2
Section
Disorders of other endocrine glands (E20-E35)
- 3
Category E29
Testicular dysfunction
- 4
Code E29.1
Testicular hypofunction
Notes for this code
Inclusion terms
- Defective biosynthesis of testicular androgen NOS
- 5-Alpha-reductase deficiency (with male pseudohermaphroditism)
- Testicular hypogonadism NOS
Code first
No “code first” instruction is listed for E29.1.
Use additional code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes1
Conditions that should not be reported together with this code.
- postprocedural testicular hypofunction (E89.5)
Excludes2
Conditions not included here that may be reported separately when present.
No Excludes2 note is listed for E29.1.
Source and release
- Data release
- U.S. ICD-10-CM · FY 2027
- Effective date
- Oct 1, 2026
- Publisher
- Vero Scribe Inc.
This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.
Frequently asked questions
What does ICD-10-CM code E29.1 mean?
E29.1 is the FY 2027 U.S. ICD-10-CM code for “Testicular hypofunction.”
Is E29.1 a billable or specific ICD-10-CM code?
Yes. In the FY 2027 reference data used on this page, E29.1 has no child codes and is presented as a billable/specific code. Always confirm the active code set and payer requirements before use.
Where is E29.1 located in ICD-10-CM?
E29.1 is listed in Chapter 4, Endocrine, nutritional and metabolic diseases (E00-E89), within Disorders of other endocrine glands (E20-E35) (E20–E35), under category E29, Testicular dysfunction.
What coding notes are listed for E29.1?
Its listed inclusion terms are Defective biosynthesis of testicular androgen NOS; 5-Alpha-reductase deficiency (with male pseudohermaphroditism); Testicular hypogonadism NOS. No code-first instruction is listed. Additional-code instructions: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5). Excludes1 notes: postprocedural testicular hypofunction (E89.5). No Excludes2 note is listed.